Physician profile
Marjorie S Soltis
NPI 1396109427
$48,386.51
in general payments reported to CMS, 2019-2025
7 companies · $7,536 in 2025
The $7,536 reported for 2025 was more than what 91% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.25 · 2022: $6,590 · 2023: $18K · 2024: $16K · 2025: $7,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Consulting Fee: $13K · Travel and Lodging: $5,160 · Food and Beverage: $2,357 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,196.00 |
| Consulting Fee | $12,940.50 |
| Travel and Lodging | $5,159.54 |
| Food and Beverage | $2,356.67 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $47,431.28 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $320.23 | 2023-2025 | Lumryz |
| E.R. Squibb & Sons, L.L.C. | $204.30 | 2022 | |
| Axsome Therapeutics, INC. | $125.00 | 2024 | Sunosi |
| Harmony Biosciences LLC | $112.37 | 2023 | Wakix |
| Ucb, INC. | $110.08 | 2023 | Fintepla |
| Alexion Pharmaceuticals, INC. | $83.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Soltis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.